These findings suggest that TREM1 silencing alters key signaling pathways in a cell-type-specific manner, disrupting nuclear functions in Huh7 cells and extracellular signaling in HepG2 cells, while also impairing cancer stem cell properties in both cell lines. This evidence concerns the gene TREM1 and cancer.